Breakthrough Clinical Study Confirms LumaGEM’s Molecular Breast Imaging (MBI)’s High Cancer Detection Rate in Dense Breast Tissue Following Cancer-Negative Mammograms Breakthrough Clinical Study Confirms LumaGEM’s Molecular Breast Imaging (MBI)’s High Cancer Detection Rate in Dense Breast Tissue Following Cancer-Negative Mammograms

…at the ProMedica Breast Care Center, where the research took place. The community-based study used data from routine clinical practice at the… to serving the need of a vast patient population to be certain about their breast health.” About Gamma Medica, Inc. Gamma Medica, Inc. is a women’s…

gammamedica.com

Total Shares: 0

from Data Alerts http://ift.tt/2apXthJ
via IFTTT

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

WordPress spam blocked by CleanTalk.